Ultimate Assessment Program 2027/28/29 || 1:1 Mentorship Batch Admissions Open

Science and Technology › Vaccines

India unveils first indigenous H5N1 vaccine: ‘An example of self-reliance’

·

Why in the News

For the first time, India has an indigenous vaccine against H5N1, the highly pathogenic strain of avian influenza (bird flu). Scientists at the Indian Council of Agricultural Research (ICAR)-National Institute of High Security Animal Diseases (NIHSAD), Bhopal, developed it, and the Union Agriculture Minister dedicated it to the nation at Rs 1-2 per dose. The stake is cheaper, home-grown protection for poultry farmers hit by bird flu.

What is the H5N1 vaccine, and why does it matter?

  1. What it is: A vaccine trains a bird’s immune system to recognise the H5N1 virus in advance, so a vaccinated chicken resists infection. It works like a flu shot for poultry.
  2. Why it was needed: Bird flu causes large-scale chicken deaths and huge economic losses for poultry farmers.
  3. Who built it: NIHSAD is ICAR’s institute for high-risk animal pathogens. Its team worked for months under strict biosafety protocols (rules that stop pathogens escaping a laboratory), even avoiding pets at home to keep infection out.
  4. Wider access: A low-priced indigenous vaccine makes disease prevention more accessible to poultry farmers and can reduce dependence on external technologies.
  5. The takeaway: India can now protect its poultry against bird flu with its own technology, which the Minister called “an example of India’s self-reliance”.

Why does animal disease matter to rural incomes?

  1. Livelihood stake: Livestock and poultry are essential sources of regular income for rural households.
  2. Disease burden: Foot and Mouth Disease, Lumpy Skin Disease, Brucellosis and Peste des Petits Ruminants together cause annual losses of about Rs 56,000 crore, per government estimates.

What else is India doing against animal disease?

  1. New laboratory: The Minister announced a Rs 300-crore state-of-the-art laboratory at NIHSAD to research high-risk animal pathogens and develop vaccines.
  2. FMD vaccination: About 147.16 crore free doses against Foot and Mouth Disease (FMD) have been given under the National Animal Disease Control Programme (NADCP).
  3. Lumpy skin response: India developed the Lumpi-ProVacInd vaccine after the 2022 Lumpy Skin Disease outbreak.

Challenges

  1. Culling-led control: India has fought bird flu outbreaks mainly by culling poultry around infected sites, so vaccination needs a policy shift.
  2. Masked infection: Vaccinated birds can carry the virus without falling ill, which makes outbreaks harder to detect.
  3. Trade restrictions: Some importing countries restrict poultry from flocks vaccinated against bird flu.
  4. Changing virus: Influenza viruses mutate, so the vaccine strain must keep pace with circulating strains.

Way Forward

  1. Clear vaccination policy: The Department of Animal Husbandry and Dairying should set where vaccination complements culling.
  2. Surveillance alongside vaccination: Pair vaccination with tests that tell vaccinated birds from infected ones.
  3. Strain tracking: NIHSAD should monitor circulating strains and update the vaccine.
  4. Scale-up: Transfer the technology to manufacturers so supply reaches small and backyard poultry keepers at low cost.

Conclusion

India now has a home-grown, low-cost shield against bird flu, but it protects farmers only once it is built into the national control strategy. How quickly the vaccine is produced at scale and folded into India’s bird flu response is what to watch.

Back2Basics: H5N1 avian influenza

  1. Virus type: H5N1 is a subtype of the influenza A virus, named after its haemagglutinin (H) and neuraminidase (N) surface proteins.
  2. Highly pathogenic: “Highly pathogenic” means the strain kills a large share of infected poultry, often within days.
  3. Spread: Migratory wild birds, especially waterfowl, carry the virus and pass it to domestic poultry.
  4. Zoonotic risk: It can occasionally infect humans in close contact with infected birds.

Matching Previous Year Question

“[2022, GS3, 15 marks] What is the basic principle behind vaccine development? How do vaccines work? What approaches were adopted by the Indian vaccine manufacturers to produce COVID-19 vaccines?”

Click here to Download X-Factor Notes for FREE. Cover the entire Microthemes with PYQs.

Download free X-Factor Notes
Revised and updated X-Factor Notes for UPSC Mains 2026: nine subject booklets